Inspira Technologies
Script error: No such module "AfC submission catcheck".
| Public | |
| Traded as | NASDAQ: IINN NASDAQ: IINNW |
| ISIN | 🆔 |
| Industry | Medical device |
| Founded 📆 | 2018 [1] |
| Founder 👔 | Joe Hayon (President and CFO) Dagi Ben-Noon (CEO) Udi Nussinovitch [2] |
| Headquarters 🏙️ | , |
Area served 🗺️ | |
Key people | Benad Goldwasser [4] |
| Products 📟 | Inspira ART (respiratory support system)
ALICE CPB device HYLA blood sensor |
| Members | |
Number of employees | 26 [5] |
| 🌐 Website | inspira-technologies |
| 📇 Address | |
| 📞 telephone | |
Inspira Technologies Oxy B.H.N. Ltd is an Israeli-based medical device company specializing in respiratory care solutions. It is a publicly-traded company listed on the NASDAQ stock exchange (NASDAQ: IINN/IINNW).[6] The company is developing technologies to assist patients suffering from respiratory failure, with its main technology being the Inspira ART system that directly oxygenates blood to rebalance oxygen saturation levels while patients are awake and breathing spontaneously, potentially minimizing the need for invasive mechanical ventilation. [1]
History[edit]
The company was established in 2018. The founders are Dagi Ben-Noon (CEO), former co-founder and COO of Nano Dimension (NASDAQ: NNDM), Joe Hayon (President), former CIO of Plasan, and Dr. Udi Nussinovitch, M.D. [7] In February 2021, the company appointed professor Benad Goldwasser, healthcare entrepreneur, as its Chairman of the board. [8] In January 2022, it appointed Daniel Brodie to its scientific advisory board. Brodie is the president of Extracorporeal Life Support Organization and a full professor at the Columbia University Department of Medicine.[9]
Overview[edit]
Between 2019-2020, Inspira Technologies raised $12 million from Israeli, American and Australian angel investor, family offices and small VC’s[1] and received a grant from the Israel Innovation Authority.[10] In July 2021, it raised $16 million in an IPO on the NASDAQ, As of November 2021, the company had $26 million in cash. In October 2021, the company raised an additional $9.4 million through investors exercising tradeable warrants at an exercise price of $5.50 per share. As of November June 30, 2022, the company had $$19.2 million in cash on-hand.[11]
See also[edit]
References[edit]
- ↑ 1.0 1.1 1.2 Hillel Fuld (March 18, 2021). Hillel's Tech Corner: Inspira makes breathing easy. The Jerusalem Post.
- ↑ Zeli Greenberg (February 10, 2021). Covid-19 skyrocket Inspira's IPO aspirations. Calcalist.
- ↑ (October 27, 2021). FORM F-1. SEC. p. 1.
- ↑ Form F-20 (For the fiscal year ended December 31, 2021). SEC. p. 73-74.
- ↑ Form F-20 (For the fiscal year ended December 31, 2021). SEC. p. 92.
- ↑ (February 21, 2021). Sheba Hospital tests Israeli startups' respiratory Tech on COVID-19 patients. No camels.
- ↑ Gali Weinreb (March 23, 2020). In due course, Inspira developed a new respiration technique. Globes.
- ↑ James Spiro (February 24, 2021). Inspira Technologies appoints Benad Goldwasser as Chairman of the Board. Calcalist.
- ↑ (January 19, 2022). Professor Daniel Brodie, the President of the International Extracorporeal Organization (ELSO) and Director of Critical Care from New-York Columbia - Presbyterian Hospital, Has Joined Inspira Technologies' Advisory Board. PR Newswire.
- ↑ Jenya Volinsky (March 24, 2020). An Israeli company that developed substitute to MV machine will be enlisted in the Australian Securities Exchange. TheMarker.
- ↑ Inspira Technologies Reports Second Quarter 2022 Financial Results. (August 11, 2022).
External links[edit]
- Official website
- Business data for Inspira Technologies: Google Finance, Yahoo! Finance, SEC filings
This article "Inspira Technologies" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Inspira Technologies. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
